COVID-19 vaccine immunogenicity in people living with HIV
Comparing COVID-19 vaccine immunogenicity in people living with HIV to HIV-negative individuals
View PublicationComparing COVID-19 vaccine immunogenicity in people living with HIV to HIV-negative individuals
View PublicationReporting that people living with HIV diagnosed with coronary artery atherosclerotic plaques display higher levels of HIV DNA compared to those without atherosclerotic plaques
View PublicationExploring associations between community connectedness and treatment interruptions among gay, bisexual and other men who have sex with men living with HIV in Vancouver, British Columbia
View PublicationExamining the feasibility of using ecological momentary assessment to disentangle medicinal cannabis use (MCU) from recreational cannabis use among people living HIV
View PublicationExamining how public health measures during COVID-19 impacted the sexual practices of sexual minority men and how they adopted and modified guidelines to prevent the transmission of COVID-19, HIV and other sexually transmitted infections (STIs)
View PublicationDescribing the development of a web-based tailored intervention, TAVIE en santé, to support people living with HIV in the adoption of healthy behaviors
View PublicationIdentifying the prevalence and correlates of violence by any perpetrator among women living with HIV in a Canadian setting
View PublicationExamining differences over time in PrEP uptake and assessed factors associated with PrEP awareness and use
View PublicationAscertaining feasibility, acceptability, and efficacy potential of GMT for people (≥50 years) with stable HIV infection scoring low on tests of cognitive ability
View PublicationExamining trends in virologic suppression and determinants of significant viremia among a prospective biobehavioural cohort of men who have sex with men in Vancouver
View Publication